If we thought
last September that the 'Indian MHA saga' was set to complete quickly, we were
wrong.
Four years and
four months after the stimulant, methylhexaneamine (MHA), came to haunt some of
the top sportspersons of the country, just ahead of the New Delhi Commonwealth
Games, one among the ‘batch of 11’ MHA cases is still unresolved.
Of the 11 MHA
cases that went into disciplinary procedures in September, 2010, one, that of
swimmer Amar Muralidharan, is yet to be decided despite the Indian panels
having disposed of the case.
The last of the
MHA case appeals from the 2010 batch to be disposed of at the national level
was that of swimmer Richa Mishra in October last year.
CAS hearing on Jan 16
Amar
Muralidharan’s case will come up, yet again in appeal, this time before the
Court of Arbitration for Sport (CAS) at a sitting in Abu Dhabi this Friday,
January 16.
Muralidharan’s
appeal to CAS, to be heard by a single arbitrator, is a rare instance of a
‘national-level’ athlete approaching the highest court in sports arbitration. It
was a case that was heard and dismissed by an appeal panel at the national
level.
The details of
the grounds on which Muralidharan has filed his appeal with CAS are not known.
From the information gathered from sources it would seem that the swimmer has again
stressed on the points that came up at his hearings in India. These primarily
relate to ‘chain of custody’ of the sample and the confusion generated by the
National Dope Testing Laboratory (NDTL) in allotting laboratory code numbers
that mixed up the names of Muralidharan and another swimmer Jyotsana Pansare.
One additional
point that seems to have been made relates to the composition of the National
Anti-Doping Appeal Panel (NADAP). As per the then existing rules of the
National Anti Doping Agency (NADA) such a panel had to be composed of four
members.
Since 2009, the
NADAP has been composed of three members only. The Muralidharan case was also
heard by a three-member panel, headed by Justice M. L. Varma (retd.). The other
members of the panel were Dr V. K. Sharma and former table tennis international
Indu Puri.
Rules amended
The NADA rules
of 2010 (based on the 2009 WADA Code) stipulated that the appeal panel would
comprise a chair, a legal practitioner, one medical practitioner, a sports
administrator and a “renowned athlete who has retired from active sports”.
The WADA model
rules for 2009 did not specify the number of persons to be nominated to an
appeal panel. It was presumed that just like in the case of disciplinary panel
it would be a three-member panel.
How the
discrepancy came about in the composition of the NADAP and how for five years different
panels functioned without checking up the rules will remain a matter of conjecture.
The latest NADA
rules, based on the revised Code of 2015, have amended the provisions to
specify that it would be a three-member panel. The third member would either be
a sports administrator or a sportsperson.
Whether this
discrepancy would be viewed seriously by the CAS arbitrator is to be seen only.
Muralidharan
argued before the disciplinary panel that the ‘chain of custody’ during the
four-day period the sample took from Jaipur to Delhi was in doubt and that
there were variations in the pH of the ‘A’ and ‘B’ samples.
The most important
point stressed during the disciplinary panel proceedings seemed to be the
discrepancy in the lab code that was mixed up with that of Pansare.
Muralidharan tended to argue, through his lawyer, R. K. Anand, that there could
be a doubt as to the contention that his sample had tested positive for MHA.
The same points
were brought up before the appeal panel also where Amar Muralidharan’s father,
Cdr. Muralidharan, argued the case. The
NADAP noted that the disciplinary panel had gone into all the aspects related to ‘mix-up’ of code numbers etc and rejected
them.
CAS in the past had invariably taken a dim view of procedural irregularities by laboratories or anti-doping agencies and there could be possibilities on this front if jurisdiction is established.
CAS jurisdiction
The NADA, one of
the respondents in the appeal before CAS (the others are the NDTL and the
Ministry of Youth Affairs and Sports), is expected to base its defence on the
argument that Muralidharan was a ‘national-level’ athlete and he did not have
the right to appeal to CAS. Conversely CAS did not have jurisdiction over this matter according to NADA argument.
NADA is expected
to argue that having exhausted his right of appeal before the Justice Varma
panel, the swimmer did not have the right to seek another appeal.
The
International Swimming Federation (FINA) anti-doping rules define an
‘international-level’ athlete as one who is in its Registered Testing Pool (RTP).
The top-12 swimmers is each event are included in the RTP by FINA.
One could not readily
find precedents that could be compared to the Muralidharan appeal in CAS. The
one that could come close to a comparison is that of South African marathon
runner Gert Thys.
Thys who tested
positive for steroid 19-norandrosterone after winning the 2006 Seoul international
marathon, was suspended for 32 months by Athletics South Africa (ASA). The
hearing process took more than two years.
The South
African athlete went in appeal to CAS which annulled the ASA disciplinary panel
decision. CAS found procedural irregularities in the tests conducted at the
Seoul laboratory and ruled in the athlete’s favour.
Gert Thys precedent
Despite ASA’s
contention that Thys was not an ‘international-level’ athlete at the time of
the doping infraction, CAS entertained the appeal on the argument that the IAAF
anti-doping administrator had written a letter to Thys to “offer” a “settlement”
for a two-year ban if the athlete admitted his offence. He also pointed out
that even after CAS arbitration there could be an appeal before CAS and it
could end up in protracted, expensive processes. CAS construed this as an
arbitration window being offered.
ASA went in
appeal to the Swiss Federal Tribunal. CAS being located in Lausanne, the Swiss
Tribunal had jurisdiction over its decisions in a civil suit.
The Tribunal
ruled in favour of ASA and set aside the CAS verdict, stating that CAS did not
have jurisdiction over a ‘national-level’ athlete which Thys was found to be
within the rules of the IAAF at the time of the Seoul marathon 2006.
Swiss court ruling
“When the CAS found that the
Respondent was to be denied the status of an International-Level Athlete and
therefore it had no jurisdiction according to Art. 60.11 of the IAAF
Competition Rules, it did not violate the law”, the court said.
“The CAS wrongly found that it
had jurisdiction on the basis of the April 10, 2008 letter. Its jurisdiction
cannot rely on the applicable Federation Regulations either. The award of the CAS
of July 24, 2009 is accordingly to be annulled as a consequence of the appeal
being allowed and the CAS must be found to lack jurisdiction,” the court
stated.
Well, the case
did not end there! Thys went back to the South African Institute of Drug Free
Sports (SAIDS), which was the appellate authority over a ‘national-level’
athlete. The matter was, however, delayed at SAIDS.
When WADA found
that ‘due process’ was not being gone through in South Africa, it went in appeal
to support the athlete in CAS and sought setting aside of his suspension. ASA
gave up at this stage and informed CAS that it did not have the financial
capacity to defend a case in CAS but it would abide by any decision by the
court.
CAS upheld WADA
appeal in 2012, nearly six years
after the marathoner tested positive, and stated that Thys's due process rights are “seemingly being
ignored" in South Africa. It agreed with the WADA that he needed to
be reprieved under the circumstances even though it noted that the athlete had
tested positive.
Thys’s case drove
home the point that a ‘national-level’ athlete did not have the right of appeal
at CAS, an argument that was upheld by the Swiss Federal Court. If there happened to be
a second appeal in this case, under different circumstances, it was done by a party (WADA)
that had the right of appeal before CAS.
Since CAS has
admitted Amar Muralidharan’s appeal, it is to be presumed it could lead to an
interesting argument over jurisdiction just as in the case of Thys.